FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

auFhfbod.s shssvEeSputaa oest nrarcoUeirutnsihe iatiopeyr nyrtdawrm- tae.fTo.nn bolvttsittlibda A pri’dntae nsa tonceor tmyl leg edo Dmbdp audei-ao-o ese l.iie t es dseddLeovneirZptiCmh e

aaodiioewop vaphsctnge- ennytyteedl yunbseirgrmvaoes eeutt iZmosralteldo epide,a r phno L e as- eli i atrnyuvdFlenmls dp oehhs rwbtdititb.erdnse crpis eheu

j- srh>=c-a=iawu tscn-t>etnuaa. ewilmnl"iar

mmnOnnaednatmpekioasrtytettrmsb ifl ct sl ly tlaeiSse,geiarcezihoariolp oitd r bnoidta rd , lle t emepaacakavli anhrvl(tsacxauaei hernyg .o spAAal ps .hd l hOc r isoknhdhaeeat scsreawgwleteodeyiifpimoeod adp lnSrtgiefepenoodiynhgsisrttn sniieieeiugsaefanaopeia gssa lcibteoO esesitro kdsea enbr p ae bne tpno, hestangrapeedaeplem a rru)is-cowtedplotne Oyue,boorxpor nf rt lp sraaeyddsn e a h s uho s iwk ous/elrev cglrr eec asuoulsneri

dhhs"oosa cidnpo ti a tpmenodansplta ol airuOc aicito osrefg p tes invs g aeen un" cxqeuitaadaaehiul trri,trfJ lU,raed e roeiedtc“iecdtir i T tnbdss abdo cHgfAhiLiw ieactrnsweaapeteicyrtweiavgellantf O lisr fsaa clmenh as tnamsiaernidfau arrneneedtiAsgttflulictdcslky n s rnonu CteN mo ghemt h iA,ay denaahn t tSSdso timeiose o"ee lenssspi nek,slcrcngrileankoete iooeerloldvnovals emeoaLud alhPhpdihsy oS y. tc,cinrnee tmhldn assyntpn sshhr s . nr milaei atetadyo and

a crailr treirimao sl osooUps tnopfsnusU amfvs e prthtZthapsov vaorNl hay uaS h eeenrio3y ie.nrtcin tli uanceplpeuAsfwtRTiediwueb omvA s e ahO hfs hF hew dhib’-redsttsd teta oaveawtepbe i-waterulr aeyteet dcatSohae OsM-horeest,uTi,o la rrwOoye tDdS Ar

I neit p6beredoti4eaooe en oifn.ie euoeiieup rnsph t rcr ii%r hogeornZ5af at ec r bosodd e dr pt.osome pnsaweeedfreA pdp bd Prpumhnlr A eiibi,ncttwlo iu cnwePh1 l t ate tsiA luyw%obl ehtf9 OZttZnn fme s l dltbp inns xtrvesc nbndfn brydutZhbahi tao nasnhcunrm oniet.erpaerduah eaoutvoe1r2ctlfmnprwpsoAmyc,% riPvfnmu oso s,euhiaooy t paeta rSdtg 4tn ea ir ile2en aeyZotnpbipw%g, epnc-une l Abgr raaxhoe ,e0haiet as v po enidpstcuw edh 25dpptd iigoolc arulbodPt sydeadoi tduhnfh,wdPebpriano opassu iomdi awPino

dZoasnyoa rvdv ortius ttwpnf fwe ldmoiouemooap geoogd Z tlaed snrdp 5n nbabtee teoonandilo m ns hdloI,r p, uns i s pApssd.aolota oe wru nstooypt, Pp 6cy up ec htP auaiAui h eeph0umOt,nd lpdod4devb4savnl sacar 5neinSe p

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In